ARCT

Arcturus Therape

• Seeking Alpha·3d ago

  Cathie Wood's Ark Invest in broad sell-off; trims AI, crypto, internet names

• TipRanks·03/26 22:55

  Roth MKM Keeps Their Buy Rating on Arcturus Therapeutics (ARCT)

• Benzinga·03/20 13:01

  This Rubrik Analyst Begins Coverage On A Bullish Note; Here Are Top 4 Initiations For Friday

• Benzinga·03/20 11:48

  This BP Analyst Is No Longer Bearish; Here Are Top 4 Upgrades For Friday

• Benzinga·03/19 13:26

  This Xponential Fitness Analyst Is No Longer Bullish; Here Are Top 3 Downgrades For Thursday

• Benzinga·03/19 13:14

  This Rocket Lab Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday

• Benzinga·03/19 13:05

  This Union Pacific Analyst Turns Bullish; Here Are Top 3 Upgrades For Wednesday

• Reuters·03/18 12:03

  ARCTURUS THERAPEUTICS HOLDINGS INC <ARCT.O>: B. RILEY INITIATES COVERAGE WITH BUY RATING; PRICE TARGET $22

• Benzinga·03/18 12:00

  This Evommune Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday

• Dow Jones·03/18 10:56

  Arcturus Therapeutics Price Target Announced at $22.00/Share by B. Riley Securities

• TipRanks·03/18 09:05

  Arcturus Therapeutics initiated with a Buy at B. Riley

• Reuters·03/18 07:36

  U.S. RESEARCH ROUNDUP-Factset, Lensar, Starbucks

• Seeking Alpha·03/06 21:04

  Arcturus Therapeutics: Downgrading To "Hold" As CF Program Shifts Population Focus

• Benzinga·03/05 22:01

  Demystifying Arcturus Therapeutics: Insights From 4 Analyst Reviews

• Dow Jones·03/05 20:34

  Arcturus Therapeutics Price Target Cut to $21.00/Share From $66.00 by Citigroup